Systemic inflammation and oxidative stress post‐lung resection: Effect of pretreatment with N‐acetylcysteine
暂无分享,去创建一个
M. Griffiths | E. Lim | N. Davies | G. J. Quinlan | A. Bastin | G. Quinlan
[1] Kevin J Anstrom,et al. Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. , 2014, The New England journal of medicine.
[2] L. Raiteri,et al. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial. , 2014, The Lancet. Respiratory medicine.
[3] M. Hind,et al. Human models of acute lung injury , 2011, Disease Models & Mechanisms.
[4] M. Griffiths,et al. Biomarkers of lung injury after one‐lung ventilation for lung resection , 2011, Respirology.
[5] Roger Williams,et al. Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality , 2009, Hepatology.
[6] So Ri Kim,et al. Impact of oxidative stress on lung diseases , 2009, Respirology.
[7] P. Goldstraw,et al. The mortality from acute respiratory distress syndrome after pulmonary resection is reducing: a 10-year single institutional experience. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[8] C. Hales,et al. Oxidant stress mediates inflammation and apoptosis in ventilator‐induced lung injury , 2008, Respirology.
[9] N. Gedik,et al. Silymarin, the antioxidant component of Silybum marianum, prevents sepsis-induced acute lung and brain injury. , 2008, The Journal of surgical research.
[10] G. Verleden,et al. N-acetyl cysteine pre-treatment attenuates inflammatory changes in the warm ischemic murine lung. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[11] L. Papazian,et al. Protective Ventilation Influences Systemic Inflammation after Esophagectomy: A Randomized Controlled Study , 2006, Anesthesiology.
[12] S. Katsaragakis,et al. The degree of oxidative stress is associated with major adverse effects after lung resection: a prospective study. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[13] M. Decramer,et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial , 2005, The Lancet.
[14] S. Katsaragakis,et al. Postresectional pulmonary oxidative stress in lung cancer patients. The role of one-lung ventilation. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[15] T. D’amico,et al. Acute Lung Injury and Acute Respiratory Distress Syndrome After Pulmonary Resection , 2004, Seminars in cardiothoracic and vascular anesthesia.
[16] R. Effros. Exhaled breath condensate acidification in acute lung injury. , 2004, Respiratory medicine.
[17] B. Ouyang,et al. Intracellular glutathione in stretch‐induced cytokine release from alveolar type‐2 like cells , 2004, Respirology.
[18] T. Szakmany,et al. Lack of Effect of Prophylactic N-acetylcysteine on Postoperative Organ Dysfunction following Major Abdominal Tumour Surgery: A Randomized, Placebo-controlled, Double-blinded Clinical Trial , 2003, Anaesthesia and intensive care.
[19] J. Estrela,et al. In vivo antioxidant treatment protects against bleomycin‐induced lung damage in rats , 2003, British journal of pharmacology.
[20] P. Yap,et al. Acute phase responses following minimal access and conventional thoracic surgery. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[21] A. Arifi,et al. VATS lobectomy reduces cytokine responses compared with conventional surgery. , 2000, The Annals of thoracic surgery.
[22] A. D. de Gaudio,et al. The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock. , 2000, American journal of respiratory and critical care medicine.
[23] D. Schoenfeld,et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. , 2000, The New England journal of medicine.
[24] T. Evans,et al. Acute lung injury and acute respiratory distress syndrome after pulmonary resection. , 2000, The Annals of thoracic surgery.
[25] J. Morrow,et al. The isoprostanes: unique prostaglandin-like products of free-radical-initiated lipid peroxidation. , 1999, Drug metabolism reviews.
[26] Z. Molnár,et al. N-Acetylcysteine treatment to prevent the progression of multisystem organ failure: a prospective, randomized, placebo-controlled study. , 1999, Critical care medicine.
[27] T. Evans,et al. Postoperative lung injury and oxidative damage in patients undergoing pulmonary resection. , 1998, The European respiratory journal.
[28] Z. Molnár,et al. The effect of N-acetylcysteine on total serum anti-oxidant potential and urinary albumin excretion in critically ill patients , 1998, Intensive Care Medicine.
[29] P. Suter,et al. Treatment with N-acetylcysteine during acute respiratory distress syndrome: a randomized, double-blind, placebo-controlled clinical study. , 1997, Journal of critical care.
[30] G. Bernard,et al. A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group. , 1997, Chest.
[31] K. Reinhart,et al. Influence of N‐acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: Results from a prospective, randomized, double‐blind study , 1994, Critical care medicine.
[32] T. Evans,et al. Oxidative damage to plasma proteins in adult respiratory distress syndrome. , 1994, Free radical research.
[33] P. Herlevsen,et al. Antioxidant treatment with N‐acetylcysteine during adult respiratory distress syndrome: A prospective, randomized, placebo‐controlled study , 1992, Critical care medicine.
[34] M. Griffiths,et al. Exhaled breath condensate detects markers of pulmonary inflammation after cardiothoracic surgery. , 2004, American journal of respiratory and critical care medicine.
[35] A. Proudfoot,et al. The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage , 2004, European Journal of Clinical Pharmacology.
[36] P. Suter,et al. N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study. , 1994, Chest.